Course 2: IDN Finances and Incentives
Enrollment options
Course 2: IDN Finances and Incentives
In this course, Cindy Chen and Emma Bijesse of HMP Market Access Insights describe the various IDN revenue and profit drivers, including internal specialty pharmacy dispensing, 340B prescription acquisition, cost containment, risk- and value-based initiatives, and external payer strategies. The module also covers IDN incentives, their impact on the bottom line and clinical outcomes, and how IDNs influence treatment decisions using decision support tools, centralized formularies, and clinical pathways. It also delves into the three IDN archetypes—collaborative, integrative, and cooperative—and how those models can impact treatment decisions.
Guests cannot access this course. Please log in.